Insider Shareholders with Direct Ownership of Cogent Biosciences, Inc. (COGT)
This section provides a comprehensive overview of the insiders with direct ownership of Cogent Biosciences, Inc. (COGT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cogent Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Atlas Venture Fund Ix, L.P.
> 10% Shareholder |
3,361,535 | 0 | 3,361,535 $113 Million | 1 |
Apr 03, 2018
Added 2.72%
|
| 1,138,274 | 0 | 1,138,274 $38.2 Million | 1 |
Apr 03, 2018
Added 2.35%
|
|
|
Andrew R Robbins
President and CEO |
1,025,000 | 367,497 | 657,503 $22.1 Million | 2 |
Dec 17, 2025
Reduced 35.85%
|
|
Cole Pinnow
Chief Commercial Officer |
307,750 | 94,800 | 216,650 $7.27 Million | 3 |
Dec 17, 2025
Reduced 30.44%
|
|
John Edward Robinson
Chief Scientific Officer |
370,000 | 229,998 | 140,002 $4.7 Million | 3 |
Dec 26, 2025
Reduced 39.13%
|
|
Jessica Sachs
Chief Medical Officer |
371,296 | 237,358 | 133,938 $4.49 Million | 5 |
Dec 26, 2025
Reduced 38.16%
|
|
John L. Green
Chief Financial Officer |
352,272 | 239,820 | 131,834 $4.42 Million | 6 |
Dec 26, 2025
Reduced 36.87%
|
|
Evan Kearns
Chief Legal Officer |
300,000 | 190,602 | 109,398 $3.67 Million | 3 |
Dec 26, 2025
Reduced 37.27%
|